Furthermore, higher PSA at diagnosis compared to the time of biopsy reflects the differences in prostate cancer detection rate based on PSA level, and previous systematic screening studies also reported PSA levels >4 ng/ml in 12.5% of patients at the time of first screening [38]. Here, KLK3 is linked to prostate cancer.